CSPC Dophen Corporation
Records under this name other than patents CSPC Dophen Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to CSPC Dophen Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,357,472 | Homogenous antibody drug conjugates via enzymatic methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,471,037 | Homogenous antibody drug conjugates via enzymatic methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,639,291 | Homogenous antibody drug conjugates via enzymatic methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,285,128 | Homogenous antibody drug conjugates via enzymatic methods Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,458,818 | Anti-trophoblast cell surface antigen 2 (TROP2) antibodies and antibody drug conjugates comprising same Formerly held In force · USPTO record | In force | USPTO record |